BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
9 results:

  • 1. Treatment and prognostic implications of strong PD-L1 expression in primary hepatic sarcomatoid carcinoma.
    Radhakrishnan S; Martin CA; Vij M; Subbiah K; Raju LP; Gowrishankar G; Veldore VH; Kaliamoorthy I; Rammohan A; Rela M
    Immunotherapy; 2024 Apr; 16(6):371-379. PubMed ID: 38362631
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
    Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
    Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. schisandrin B suppresses osteosarcoma lung metastasis
    Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]    [Full Text] [Related]  

  • 6. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
    Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
    Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
    Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
    [No Abstract]    [Full Text] [Related]  

  • 8. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
    Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).
    Fujimoto T; Andoh T; Sudo T; Fujita I; Fukase N; Takeuchi T; Sonobe H; Inoue M; Hirose T; Sakuma T; Moritake H; Sugimoto T; Kawamoto T; Fukumori Y; Yamamoto S; Atagi S; Sakurai Y; Kurosaka M; Ono K; Ichikawa H; Suzuki M
    Appl Radiat Isot; 2015 Dec; 106():220-5. PubMed ID: 26278348
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.